论文部分内容阅读
“康复新滴剂”是云南大理医学院和中国科学院昆明植物研究所合作研究成功的一种新药,经滇 Q/WS 788/1985滇卫药准字(85)7—009号文批准,由昆明军区制药厂生产。该药主要供外用,但也可内服。近年发现病人口服以后,对淋巴结核、肺结核、胃溃疡等慢性病有一定的疗效。为了用药的安全,我们进一步研究了该药对人与动物二倍体细胞生长及染色体畸变的影响,以期了解该药长期口服后会不会引起致畸胎和致癌的不良反应。
“Rehabilitation New Drops” is a new drug successfully researched in cooperation between Yunnan Dali Medical College and Kunming Institute of Botany, Chinese Academy of Sciences. It is approved by Yunnan Q / WS 788/1985 (85) 7-009, Kunming Military Region pharmaceutical production. The drug is mainly for external use, but can also be taken orally. In recent years found that patients after oral administration of lymph nodes, tuberculosis, gastric ulcer and other chronic diseases have a certain effect. In order to drug safety, we further study the drug on human and animal diploid cell growth and chromosome aberration in order to understand the long-term oral administration of the drug will not cause teratogenic and carcinogenic adverse reactions.